Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Publication | Closed Access

DOI

468

Citations

References

2013

Year

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi, Fumiaki Takahashi, Hirofumi Michimae, Eizo Kimura, Daisuke Aoki, Toshiko Jobo, Shoji Kodama, Fumitoshi Terauchi,

The Lancet Oncology

Gastrointestinal OncologyConventional PaclitaxelMedicineMetronomic TherapyDose-dense PaclitaxelGynecologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyJgog 3016Ovarian Cancer